Research Article
Influence of Biological Therapeutics, Cytokines, and Disease Activity on Depression in Rheumatoid Arthritis
Table 4
Correlations between depressive symptoms and clinical assessments in RA subjects.
| | () | Pseudo | AICc | Coefficient | Odds ratio (95% CI) | value |
| Characteristics | Disease duration (years), mean ± SD | 17.56 ± 11.48 | 0.252 | 461.64 | −0.040 | 0.96 (0.88–1.05) | 0.401 | BMI, mean ± SD | 26.46 ± 5.49 | 0.144 | 557.56 | 0.028 | 1.03 (1.01–1.04) | < 0.001 | Pain score, median | 6 | 0.411 | 527.31 | 0.114 | 1.12 (1.08–1.16) | < 0.001 | Smoking, number (%) | 0 (0) | < 0.001 | 570.11 | −0.029 | 0.97 (0.77–1.22) | 0.806 | Drinking, number (%) | 13 (16) | 0.014 | 569.01 | −0.129 | 0.88 (0.69–1.11) | 0.290 | Physical activity, number (%) | 13 (16) | 0.256 | 546.22 | −0.668 | 0.51 (0.38–0.68) | < 0.001 | Biologic medication, number (%) | 42 (51) | 0.027 | 570.09 | −0.082 | 0.92 (0.73–1.18) | 0.503 | Classic medication, number (%) | 55 (67) | 0.030 | 569.89 | −0.062 | 0.94 (0.75–1.19) | 0.601 | Disease activity (patient), mean ± SD | 54.04 ± 30.16 | 0.880 | 426.21 | 0.002 | 1.01 (1.01–1.02) | < 0.001 | Disease activity (doctor), mean ± SD | 35.44 ± 27.03 | 0.890 | 419.81 | 0.013 | 1.01 (1.01–1.02) | < 0.001 | Laboratory | Sedementation velocity, mean ± SD | 26.59 ± 22.27 | 0.834 | 448.13 | 0.010 | 1.01 (1.01–1.01) | < 0.001 | C-reactive protein, mean ± SD | 11.11 ± 17.43 | 0.778 | 468.09 | 0.006 | 1.01 (1.00-1.01) | 0.007 | DAS28, mean ± SD | 5.04 ± 5.65 | 0.830 | 449.81 | 0.038 | 1.04 (1.02–1.05) | < 0.001 | Brain leukocytes, mean ± SD | 8.09 ± 3.40 | 0.707 | 484.34 | 0.010 | 1.01 (0.98–1.04) | 0.425 | Brain lymphocytes, mean ± SD | 27.10 ± 9.84 | 0.713 | 482.76 | −0.007 | 0.99 (0.98–1.00) | 0.139 | Anti-dsDNA, mean ± SD | 10.66 ± 5.30 | 0.999 | 248.28 | 0.017 | 1.02 (1.00-1.04) | 0.069 |
|
|